Biogen Inc (BIIB) Stock Price Today
Aura AI Summary
Key Stats
- $30.84BMarket Cap
- -Volume
- HealthSector
- $216.6352W High
- $122.6852W Low
- -Typical Hold Time
- $33.12BEnterprise Value
- -Div Yield
- -Trading Activity
Track Biogen Inc (BIIB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Biogen Inc has traded between a low of $122.68 and a high of $216.63, highlighting its annual price range. Buy and sell Biogen Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Most Recent News
Etsy's Executive Chair Josh Silverman sells 39,161 shares for $3.1 million.
Josh Silverman, Executive Chair of Etsy, sold 39,161 shares of the company, raising $3.1 million. This sale could indicate a personal financial decision or a strategic move by Silverman, but it does not necessarily reflect on Etsy's overall business ...
Three IPOs and three SPACs priced this week amid weak aftermarket returns; no new IPOs scheduled next week.
This week saw three IPOs and three SPACs priced, while seven IPOs and three SPACs filed for listings. Despite this activity, recent IPOs have experienced poor aftermarket returns, exemplified by SpaceX's SPAC trading below its initial price. No IPOs ...
Larry Kudlow criticizes VP JD Vance's controversial views and calls for a policy reset.
Larry Kudlow criticized Vice President JD Vance for his controversial statements and actions, including blaming Israel for a failed Iran peace deal and attacking free-market icons like Milton Friedman and Margaret Thatcher. Kudlow and others suggest ...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.